| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 157.31× | 157.31× | 136.67× | 157.13× | 196.75× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.42× | 1.42× | 1.73× | 1.82× | 1.31× | ||
| 0.75× | 0.75× | 0.92× | 0.80× | 0.73× | ||
| −1.50× | −1.50× | 0.11× | 1.84× | −0.71× | ||
| 1.93× | 1.93× | 0.09× | 1.39× | −0.56× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 196.75 | 157.13 | 136.67 | 157.31 | 157.31 | |
| Working Capital Turnover | 1.31 | 1.82 | 1.73 | 1.42 | 1.42 | |
| Asset Turnover | 0.73 | 0.80 | 0.92 | 0.75 | 0.75 | |
| Cash Conversion (CFO/Net Income) | -0.71 | 1.84 | 0.11 | -1.50 | -1.50 | |
| CFO/EBITDA | -0.56 | 1.39 | 0.09 | 1.93 | 1.93 |